Top Markets
#1 Black Phoenix Black Phoenix +829.68%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.03%
#3 Beam Beam +23.14%
#4 Not in Employment, Education, or Training Not in Employment, Education, or Training +22.59%
#5 SAFEcoin SAFEcoin +20.77%
#6 YFSX YFSX +19.30%
#7 pipedog pipedog +18.85%
#8 Official Trump Official Trump +18.64%
#9 Magma Finance Magma Finance +17.78%
#10 Nosana Nosana +15.60%
Coin of the day
Black Phoenix Black Phoenix
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
CymaBay Therapeutics, Inc. CymaBay Therapeutics, Inc.

CymaBay Therapeutics, Inc.

CBAY
Xếp hạng trong cổ phiếu #6080
CymaBay Therapeutics, Inc. is a biopharmaceutical company in the clinical... CymaBay Therapeutics, Inc. is a biopharmaceutical company in the clinical development phase, focused on discovering and delivering treatments for liver disorders and various other long-term illnesses. A key experimental therapy in their portfolio is seladelpar (MBX-8025), a selective activator of the peroxisome proliferator activated receptor delta. This compound is currently undergoing a pivotal Phase III clinical trial for primary biliary cholangitis (PBC), and has also concluded a Phase 2b study investigating its use for nonalcoholic steatohepatitis (NASH). Additionally, the company is advancing MBX-2982 through Phase 2a clinical trials, aiming to address hypoglycemia in individuals with type 1 diabetes. CymaBay maintains strategic partnerships, including a licensing arrangement with ABW Cyclops SPV LP to aid the development of seladelpar for PBC. They also possess a global license from Janssen Pharmaceuticals, Inc. to research, develop, and bring to market compounds active against an undisclosed metabolic disease target. Established in 1988 and formerly known as Metabolex, Inc., CymaBay Therapeutics, Inc. is headquartered in Newark, California.
Giá cổ phiếu
$32.48
Đồng bộ lần cuối: 2024-03-25
Vốn hóa thị trường
$2.24B
Thay đổi (1 ngày)
0.00%
Thay đổi (1 năm)
0.00%
Quốc gia
US
Giao dịch CymaBay Therapeutics, Inc. (CBAY)

Danh mục

Healthcare
Lịch sử giá cổ phiếu của CymaBay Therapeutics, Inc. (CBAY)
Giá đóng cửa cao nhất: $32.39 vào 2024-03-01

Giá đóng cửa thấp nhất: $9.00 vào 2014-02-01
Lịch sử giá cổ phiếu của CymaBay Therapeutics, Inc. từ 2014 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2024 47.52%
2023 374.76%
2022 35.77%
2021 -49.78%
2020 272.39%
2019 -77.25%
2018 -6.63%
2017 374.80%
2016 15.85%
2015 -81.43%
2014 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.88 41.07%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 49.71%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.94 461.51%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.19%
CH